Food and Drug Administration:

Status of Actions to Address Property Control Weaknesses

AIMD-99-257R: Published: Aug 10, 1999. Publicly Released: Aug 10, 1999.

Additional Materials:

Contact:

Gloria L. Jarmon
(202) 512-4476
contact@gao.gov

 

Office of Public Affairs
(202) 512-4800
youngc1@gao.gov

Pursuant to a congressional request, GAO followed up on the Food and Drug Administration's (FDA) efforts to implement GAO's recommendations addressing FDA's property control weaknesses.

GAO noted that: (1) overall, FDA has made good progress in addressing the recommendations made in GAO's report; (2) GAO's follow-up found that FDA was performing interim reconciliations of property transactions recorded in the general and subsidiary ledgers, and has begun training agency personnel in proper surplussing procedures for property and equipment; (3) in addition, FDA had written procedures for completing a fiscal year 1999 comprehensive inventory of property and equipment agencywide, which was underway during this review; and (4) however, FDA had not yet developed written procedures for conducting component-specific spot audits to ensure compliance with procedures related to property management, nor had FDA finalized and implemented procedures for the processing and reporting of lost, stolen, and damaged property and equipment.

Sep 20, 2016

Sep 6, 2016

Aug 19, 2016

Aug 12, 2016

Jul 29, 2016

Jul 28, 2016

Jul 13, 2016

Jul 11, 2016

Jun 13, 2016

Looking for more? Browse all our products here